Loxo Oncology Inc.

(LOXO) Trade

By |

Profile

Loxo Oncology Inc is a biopharmaceutical company. It is engaged in the development of selective medicines for patients with genetically defined cancers.

Contact Information

Website: www.loxooncology.com
Email: prahmer@troutgroup.com
Main Phone: +1 203 653-3880
Address: 281 Tresser Boulevard
Address 2: 9th Floor
State: CT
City / Town: Stamford
Country: USA
Postal Code: 06901

Issuer Information

Exchange: NSD
CEO: Joshua H. Bilenker
Employees: 96
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 155.34 $ -2.25 (-1.43%)
Last Price 155.34 Change $ -2.25 Change % -1.43 Tick N/A
Bid 155.15 Bid Size 400.00 Ask 155.50 Ask Size 100.00
Open 158.16 High 159.75 Low 153.67 Prev Close 157.59
Last Trade Volume 187,123 52 Wk Hi 208.95 52 Wk Low 71.45
Market Cap 4.7 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 30,470,070.00 EPS (TTM) -3.59 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 74 278
Number of Buys 14 55
Number of Sells 60 223
Net Activity -5000 -1620500
Last 10 Buys Shares
Andrew N. Schiff 1,000
Andrew N. Schiff 1,000
Andrew N. Schiff 1,000
Andrew N. Schiff 1,000
Avi Z. Naider 1,000
Andrew N. Schiff 1,000
Andrew N. Schiff 1,000
Steven A. Elms 1,000
Dov A. Goldstein 1,000
Avi Z. Naider 1,000
Last 10 Sell Shares
Timothy M. Mayleben 1,000
Alan Fuhrman 1,000
Keith Flaherty 1,000
Keith Flaherty 1,000
Keith Flaherty 1,000
Keith Flaherty 1,000
Keith Flaherty 1,000
Keith Flaherty 1,000
Keith Flaherty 1,000
Joshua H. Bilenker 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 225 190 190 225
Low Target Price Estimate 122 122 122 122
Mean Target Price Estimate 189 158.25 158.25 189
Standard Deviation 42.54 28.94 28.94 42.54
Date of Most Recent Estimate 06/04/18 05/17/18 05/17/18 06/04/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 6 6 6 6
Moderate Buy 1 1 0 1
Hold 1 1 2 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.31 1.31 1.5 1.31